These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 18590994)
1. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Lanfranco F; Zirilli L; Baldi M; Pignatti E; Corneli G; Ghigo E; Aimaretti G; Carani C; Rochira V Bone; 2008 Sep; 43(3):628-35. PubMed ID: 18590994 [TBL] [Abstract][Full Text] [Related]
2. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. Maffei L; Rochira V; Zirilli L; Antunez P; Aranda C; Fabre B; Simone ML; Pignatti E; Simpson ER; Houssami S; Clyne CD; Carani C Clin Endocrinol (Oxf); 2007 Aug; 67(2):218-24. PubMed ID: 17547681 [TBL] [Abstract][Full Text] [Related]
3. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone. Rochira V; Zirilli L; Madeo B; Aranda C; Caffagni G; Fabre B; Montangero VE; Roldan EJ; Maffei L; Carani C Bone; 2007 Jun; 40(6):1662-8. PubMed ID: 17400043 [TBL] [Abstract][Full Text] [Related]
4. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters. Rochira V; Faustini-Fustini M; Balestrieri A; Carani C J Clin Endocrinol Metab; 2000 May; 85(5):1841-5. PubMed ID: 10843162 [TBL] [Abstract][Full Text] [Related]
5. The effects of long-term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency. Zirilli L; Maffei L; Meunier PJ; Chavassieux P; Carani C; Rochira V Bone; 2009 Nov; 45(5):827-32. PubMed ID: 19345749 [TBL] [Abstract][Full Text] [Related]
6. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. Herrmann BL; Saller B; Janssen OE; Gocke P; Bockisch A; Sperling H; Mann K; Broecker M J Clin Endocrinol Metab; 2002 Dec; 87(12):5476-84. PubMed ID: 12466340 [TBL] [Abstract][Full Text] [Related]
7. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia. Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524 [TBL] [Abstract][Full Text] [Related]
8. Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency. Verma N; Jain V; Birla S; Jain R; Sharma A J Pediatr Endocrinol Metab; 2012; 25(11-12):1185-90. PubMed ID: 23329769 [TBL] [Abstract][Full Text] [Related]
9. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. Smith EP; Boyd J; Frank GR; Takahashi H; Cohen RM; Specker B; Williams TC; Lubahn DB; Korach KS N Engl J Med; 1994 Oct; 331(16):1056-61. PubMed ID: 8090165 [TBL] [Abstract][Full Text] [Related]
10. Bone metabolism in men: role of aromatase activity. Nuti R; Martini G; Merlotti D; De Paola V; Valleggi F; Gennari L J Endocrinol Invest; 2007; 30(6 Suppl):18-23. PubMed ID: 17721069 [TBL] [Abstract][Full Text] [Related]
11. Impact of estrogen replacement throughout childhood on growth, pituitary-gonadal axis and bone in a 46,XX patient with CYP19A1 deficiency. Janner M; Flück CE; Mullis PE Horm Res Paediatr; 2012; 78(4):261-8. PubMed ID: 22964562 [TBL] [Abstract][Full Text] [Related]
12. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. Maffei L; Murata Y; Rochira V; Tubert G; Aranda C; Vazquez M; Clyne CD; Davis S; Simpson ER; Carani C J Clin Endocrinol Metab; 2004 Jan; 89(1):61-70. PubMed ID: 14715828 [TBL] [Abstract][Full Text] [Related]
14. Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency. Herrmann BL; Janssen OE; Hahn S; Broecker-Preuss M; Mann K Horm Metab Res; 2005 Mar; 37(3):178-83. PubMed ID: 15824973 [TBL] [Abstract][Full Text] [Related]
15. Aromatase deficiency in men: a clinical perspective. Rochira V; Carani C Nat Rev Endocrinol; 2009 Oct; 5(10):559-68. PubMed ID: 19707181 [TBL] [Abstract][Full Text] [Related]
16. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. Mullis PE; Yoshimura N; Kuhlmann B; Lippuner K; Jaeger P; Harada H J Clin Endocrinol Metab; 1997 Jun; 82(6):1739-45. PubMed ID: 9177373 [TBL] [Abstract][Full Text] [Related]
18. Of mice and men: the evolving phenotype of aromatase deficiency. Jones ME; Boon WC; Proietto J; Simpson ER Trends Endocrinol Metab; 2006 Mar; 17(2):55-64. PubMed ID: 16480891 [TBL] [Abstract][Full Text] [Related]
19. Role of estrogen and androgen in pubertal skeletal physiology. Frank GR Med Pediatr Oncol; 2003 Sep; 41(3):217-21. PubMed ID: 12868122 [TBL] [Abstract][Full Text] [Related]
20. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Morishima A; Grumbach MM; Simpson ER; Fisher C; Qin K J Clin Endocrinol Metab; 1995 Dec; 80(12):3689-98. PubMed ID: 8530621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]